PAL 0.00% 29.5¢ palla pharma limited

In my opinion no capital raising is to be expected. Their debt...

  1. 2,339 Posts.
    lightbulb Created with Sketch. 262
    In my opinion no capital raising is to be expected. Their debt levels are a bit high especially with the new debt from SOL but it should be considered manageable at the present moment. Profits should be OK to cover debt and interest.

    "Expectations of a modest Operating EBITDA profit for 1H2019 compared to an Operating EBITDA loss of $1.8 million for the prior corresponding period despite the incurrence of non‐recurring legal expenses and an increased investment in research and development."

    Last year result was a loss around 5 million.
 
watchlist Created with Sketch. Add PAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.